SE9801368D0 - New use - Google Patents
New useInfo
- Publication number
- SE9801368D0 SE9801368D0 SE9801368A SE9801368A SE9801368D0 SE 9801368 D0 SE9801368 D0 SE 9801368D0 SE 9801368 A SE9801368 A SE 9801368A SE 9801368 A SE9801368 A SE 9801368A SE 9801368 D0 SE9801368 D0 SE 9801368D0
- Authority
- SE
- Sweden
- Prior art keywords
- value
- glucocorticosteroid
- reversibility
- copd
- patients
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9801368A SE9801368D0 (sv) | 1998-04-20 | 1998-04-20 | New use |
BR9909786-9A BR9909786A (pt) | 1998-04-20 | 1999-03-18 | Utilização de um glucocorticosteroide para a fabricação de um medicamento para tratar formas brandas/ precoces de copd (doença pulmonarobstrutiva crÈnica |
EP99912204A EP1073441A1 (fr) | 1998-04-20 | 1999-03-18 | Utilisation d'un glucocorticosteroide dans la preparation d'un medicament permettant de traiter les formes legeres/precoces de bpco (bronchopneumopathie chronique obstructive) |
JP2000544330A JP2002512193A (ja) | 1998-04-20 | 1999-03-18 | 軽度/初期型のcopd(慢性閉塞性肺疾患)を処置することを目的とした薬物の製造のための糖質副腎皮質ステロイドの使用 |
CN99807636A CN1306429A (zh) | 1998-04-20 | 1999-03-18 | 糖皮质类固醇在制备治疗轻度/早期c opd(慢性阻塞性肺病)的药物中的应用 |
CA002329008A CA2329008A1 (fr) | 1998-04-20 | 1999-03-18 | Utilisation d'un glucocorticosteroide dans la preparation d'un medicament permettant de traiter les formes legeres/precoces de bpco (bronchopneumopathie chronique obstructive) |
PCT/SE1999/000426 WO1999053926A1 (fr) | 1998-04-20 | 1999-03-18 | Utilisation d'un glucocorticosteroide dans la preparation d'un medicament permettant de traiter les formes legeres/precoces de bpco (bronchopneumopathie chronique obstructive) |
AU30625/99A AU3062599A (en) | 1998-04-20 | 1999-03-18 | Use of a glucocorticosteroid for the manufacture of a medicament for treating mild/early forms of copd (chronic obstructive pulmonary disease) |
ARP990101816A AR018191A1 (es) | 1998-04-20 | 1999-04-20 | Uso de glucocorticosteroides para la manufactura de un medicamento para tratar enfermedades pulmonares obstructivas cronicas |
HK02100375.3A HK1038703A1 (zh) | 1998-04-20 | 2002-01-17 | 糖皮質類固醇在制備治療輕度/早期copd(慢性阻塞性肺病)的藥物中的應用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9801368A SE9801368D0 (sv) | 1998-04-20 | 1998-04-20 | New use |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9801368D0 true SE9801368D0 (sv) | 1998-04-20 |
Family
ID=20411015
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9801368A SE9801368D0 (sv) | 1998-04-20 | 1998-04-20 | New use |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1073441A1 (fr) |
JP (1) | JP2002512193A (fr) |
CN (1) | CN1306429A (fr) |
AR (1) | AR018191A1 (fr) |
AU (1) | AU3062599A (fr) |
BR (1) | BR9909786A (fr) |
CA (1) | CA2329008A1 (fr) |
HK (1) | HK1038703A1 (fr) |
SE (1) | SE9801368D0 (fr) |
WO (1) | WO1999053926A1 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9912534D0 (en) | 1999-05-29 | 1999-07-28 | Glaxo Group Res Ltd | Novel prognostic surrogate |
ECSP003747A (es) * | 1999-11-02 | 2002-05-23 | Smithkline Beecham Corp | Metodo y composiciones para el tratamiento de las enfermedades pulmonares |
PT1572217E (pt) | 2002-12-12 | 2008-11-28 | Nycomed Gmbh | Medicamento combinado de r,r-formoterol e ciclesonida |
WO2004070058A1 (fr) * | 2003-02-03 | 2004-08-19 | Bayer Healthcare Ag | Methodes et compositions permettant de prevoir, diagnostiquer, pronostiquer, prevenir et traiter des broncho-pneumopathies chroniques obstructives |
TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
PT1670482E (pt) | 2003-09-16 | 2014-03-12 | Takeda Gmbh | Utilização de ciclesonida para o tratamento de doenças respiratórias |
WO2005030220A1 (fr) * | 2003-09-26 | 2005-04-07 | Schering Corporation | Traitement de maladie pulmonaire |
AU2005235384B2 (en) * | 2004-04-20 | 2010-09-09 | Covis Pharma B.V. | Use of ciclesonide for the treatment of respiratory diseases in a smoking patient |
-
1998
- 1998-04-20 SE SE9801368A patent/SE9801368D0/xx unknown
-
1999
- 1999-03-18 WO PCT/SE1999/000426 patent/WO1999053926A1/fr not_active Application Discontinuation
- 1999-03-18 AU AU30625/99A patent/AU3062599A/en not_active Abandoned
- 1999-03-18 CN CN99807636A patent/CN1306429A/zh active Pending
- 1999-03-18 JP JP2000544330A patent/JP2002512193A/ja active Pending
- 1999-03-18 EP EP99912204A patent/EP1073441A1/fr not_active Withdrawn
- 1999-03-18 CA CA002329008A patent/CA2329008A1/fr not_active Abandoned
- 1999-03-18 BR BR9909786-9A patent/BR9909786A/pt not_active IP Right Cessation
- 1999-04-20 AR ARP990101816A patent/AR018191A1/es unknown
-
2002
- 2002-01-17 HK HK02100375.3A patent/HK1038703A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
EP1073441A1 (fr) | 2001-02-07 |
HK1038703A1 (zh) | 2002-03-28 |
WO1999053926A1 (fr) | 1999-10-28 |
JP2002512193A (ja) | 2002-04-23 |
BR9909786A (pt) | 2000-12-19 |
CA2329008A1 (fr) | 1999-10-28 |
AR018191A1 (es) | 2001-10-31 |
CN1306429A (zh) | 2001-08-01 |
AU3062599A (en) | 1999-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1105199T1 (el) | Θepαπευτικες συνθεσεις για αντιμετωπιση της υπepεκκρισης βλεννας | |
ATE252912T1 (de) | Pharmazeutische zusammensetzung zur behandlung einer funktionalen dyspepsie und/oder des reizdarmsyndroms und die verwendung neuer substanzen in dieser zusammensetzung | |
KR950002785A (ko) | 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜 | |
BR0008276A (pt) | Combinações de formoterol e propionato de fluticasona para asma | |
BR0015974A (pt) | Uso de levetiracetam, composição farmacêutica, uso de uma composição farmacêutica e métodos para tratar um paciente admintstrado com uma quantidade de pelo menos um composto e uma doença e para potenciar seletivamente o efeito terapêutico de um composto | |
ATE330589T1 (de) | Pharmazeutische zusammensetzung enthaltend resveratrol zur behandlung von entzündlichen erkrankungen der atemwege | |
BR0111591A (pt) | Compostos, composição farmacêutica, e, métodos para elevar o nìvel de plasma do hormÈnio de crescimento em um mamìfero, para o tratamento de deficiência da secreção do hormÈnio de crescimento, para o tratamento do retardo do crescimento em crianças, para o tratamento de distúrbios metabólicos associados com a deficiência da secreção do hormÈnio de crescimento, em particular em pacientes idosos, e para promover a cura de ferimentos, recupeção de cirurgia ou recuperação de doenças debilitantes | |
BG106095A (en) | Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics | |
ATE204178T1 (de) | Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin | |
Wang et al. | Adding corticosteroids to periarticular infiltration analgesia improves the short-term analgesic effects after total knee arthroplasty: a prospective, double-blind, randomized controlled trial | |
BR9811825A (pt) | Uso de lactobacillus para redução do nìvel de fibrinogênio no sangue | |
BR9713921A (pt) | Composto, composição farmacêutica, processo para tógico capaz de ser modulado através da inibição do fator xa | |
SE9801368D0 (sv) | New use | |
PE11399A1 (es) | Combinacion de loratadina y un descongestionante para el tratamiento del asma | |
DE69424777D1 (de) | 3,4-diarylchromane zur behandlung von dermatitis | |
Harper et al. | Non-union of Colles' fracture: report of two cases | |
BR9809678A (pt) | Derivados de triptolìdeo úteis no tratamento de doenças autoimunes | |
WO2002039999B1 (fr) | Inhibition d'angiogenese du type endostatine | |
Ejnell et al. | Treatment of postoperative pain with diclofenac in uvulopalatopharyngoplasty | |
BR9809673A (pt) | Derivados de triptolida úteis no tratamento de doenças autoimunes | |
EA200200518A1 (ru) | Способ и композиция для лечения заболеваний легких | |
RU98114080A (ru) | Биологически активные этанамины бензотиазолона | |
Pribitkin et al. | Efficacy of laser-assisted uvulopalatoplasty in obstructive sleep apnea | |
SE9303612D0 (sv) | New use | |
ATE214926T1 (de) | Verwendung von (r-(z))-alpha-(methoxyimino)-alpha-(1-azabicycl (2.2.2.) oct-3-yl) acetonitril zur hemmung der amyloid-beta-a4-bildung bei der alzheimerschen krankheit |